ETF Database explains the peptide economy beyond the GLP-1 boom
An investor explainer on how the peptide market reaches past GLP-1 weight loss drugs.
Recap by typeshit. Full story at ETF Database.
An investor explainer on how the peptide market reaches past GLP-1 weight loss drugs.
Recap by typeshit. Full story at ETF Database.
2:06:18
A live Q&A from FitFlavorFun taking viewer questions on Zepbound, Ozempic, Wegovy, retatrutide and Korglutide.
People familiar with the matter say the plan under review includes more safeguards for patients than first expected. A policy step worth watching.
Celebrity paparazzi item on Amanda Bynes stepping out in a miniskirt, framed around her reported Ozempic use. Little detail beyond the photos.
The show is collecting experiences from people microdosing GLP-1 drugs, including why they tried it and how they got the medication.
The post hoc look at 2,300+ women, shown at The Menopause Society meeting, splits results by menopause stage. FDA decision expected late 2026.
Researchers in Granada report that combining intermittent fasting and exercise over 12 weeks improved fat loss and fitness in adults with obesity.
Loading…